David Enloe, Societal CDMO CEO
November 9, 2023 06:18 AM EST
Manufacturing

So­ci­etal CD­MO trims pro­ject­ed 2023 sales rev­enue de­spite third-quar­ter earn­ings bump

Anna Brown

News Reporter

So­ci­etal CD­MO is cut­ting its 2023 rev­enue fore­cast to $92 mil­lion to $94 mil­lion — down from the $94 mil­lion to $100 mil­lion it pre­dict­ed ear­li­er …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

For­bion rais­es €2.1B for two new biotech funds af­ter se­ries of com­pa­ny ex­its

Ex­clu­sive: Biotech tools com­pa­ny rais­es $75M for pro­tein man­u­fac­tur­ing tech 

Mary­land biotech gets green light for stem cell-de­rived ther­a­py for di­a­betes, aim­ing to com­pete with Ver­tex

Tol­er­ance Bio emerges from stealth with $17.2M to ad­vance ther­a­pies de­vel­oped from the thy­mus

Eli Lil­ly re­veals £279M in­vest­ment in the UK through new gov­ern­ment deal

sponsored

Join the Gen­Script Biotech Glob­al Fo­rum: Un­lock­ing In­no­va­tions in Cell and Gene Ther­a­pies

A service from the Financial Times